Dublin - Research and Markets has announced the addition of the "Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry" report to their offering. A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use.
This year's American Friends of Rabin Medical Center "Broadway on the Hudson" Gala is shaping up to be an unforgettable evening. Legendary comedian Robert Klein will be introducing the entertainment portion of the evening with his hilarious stand-up routine.
Research and Markets has announced the addition of the "Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry" report to their offering. A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use.
Dublin - Research and Markets has announced the addition of the "Cancer Therapies - Global Market Opportunities" report to their offering. Cancer therapies are geared towards controlling the growth of cancerous tumors, and preventing the spread of cancer to other organs of the body.
Despite years of controversy, new study finds that generic drugs to be equally as effective as brand name drugs. A recent publication in the October issue of The Medical Letter may help to eliminate the fear many people have about generic drugs.
Dublin - Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Pharmaceutical Market Access, Pricing, and Reimbursement News in the Second Quarter of 2009" to their offering.
Q Chip, a biopharmaceutical drug delivery company, is developing a range of sustained-release biosimilars using its patented Q-Sphera bioencapsulation platform. The first two drugs under development using the Q-Sphera delivery system are the biosimilars, Q-Leuprolide and Q-Octreotide. Encapsulation of biotherapies into bioresorbable microspheres
Research and Markets has announced the addition of the "Cancer Therapies - Global Market Opportunities" report to their offering. Cancer therapies are geared towards controlling the growth of cancerous tumors, and preventing the spread of cancer to other organs of the body.
Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Pharmaceutical Market Access, Pricing, and Reimbursement News in the Second Quarter of 2009" to their offering.
Research and Markets has announced the addition of Decision Resources, Inc.'s new report "The Pricing and Reimbursement Environment for Neurology Drugs" to their offering. Neurological disorders will impose a growing social and financial burden on the major pharmaceutical markets as the elderly population in these countries increases steadily.
Dublin - Research and Markets has announced the addition of Decision Resources, Inc.'s new report "The Pricing and Reimbursement Environment for Neurology Drugs" to their offering. Neurological disorders will impose a growing social and financial burden on the major pharmaceutical markets as the elderly population in these countries increases stead
In the news release, "Teva Launches TevaGrastim" issued on 18 Nov 2009 07:00 GMT, by Teva UK Ltd over PR Newswire, due to an omission made by PR Newswire, we did not specify that this is a black triangle drug. Teva Launches TevaGrastim. - With Photo. Teva UK Limited has signalled its commitment to developing biosimilar medicines by entering the G-C
The pharmaceutical industry is facing an impending patent cliff, when some of its biggest selling drugs will lose patent protection and become exposed to generic competition. Between 2001 and 2008, the collective revenues of 'Big Pharma' grew by 8.6% year-on-year. However, this analysis does not take into account the upcoming patent cliff.
18 November 2009 - Indian pharmaceutical and biotechnology company Wockhardt Ltd said today that the US FoodaA' and Drug Administration approved the company's 25 mg/10 ml injection of Nicardipine HCl for short-term management of hypertension or increased blood pressure. Nicardipine is the generic name for the brand Cardene, marketed in the USA by l
Impax Laboratories, Inc. confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR tablets, 48 mg and 145 mg. Impax filed its Abbreviated New Drug Application containing a Paragraph IV certification for a generic version of TRICOR with the U.S. Food & Drug Administration.
This year's American Friends of Rabin Medical Center "Broadway on the Hudson" Gala is shaping up to be an unforgettable evening. Legendary comedian Robert Klein will be introducing the entertainment portion of the evening with his hilarious stand-up routine.
Mylan Inc. today announced that Didier Barret, president of Mylan Europe, Middle East and Africa, has been elected president of the European Generic Medicines Association. Mylan Chairman and CEO Robert J. Coury said: "We are extremely pleased to have one of our own senior executives lead Europe's generic trade organization over the next two years.
Experts from PAREXEL International Corporation, a leading global biopharmaceutical services provider, will provide insights into evolving pharmacovigilance trends and their impact on biosimilars and generic products at the World Generic Medicines Congress Americas, being held November 17 - 20, 2009 in Washington, DC.
According to recent research from the United States, "In the US, manufacturers seeking approval to market a generic drug product must submit data demonstrating that the generic formulation provides the same rate and extent of absorption as the innovator drug product.
Teva Respiratory, a division of Teva Pharmaceutical Industries Ltd., announced results from an analysis of the cost-effectiveness of three different inhaled corticosteroids in a "real-life" asthmatic population. Several short-term, randomized controlled trials demonstrated that QVAR and other ICS therapies, including CFC-BDP and FP metered dos
Teva UK Limited has signalled its commitment to developing biosimilar medicines by entering the G-CSF* therapy area. TevaGrastim is licensed for a number of indications1, the most common being the reduction of chemotherapy-induced neutropenia. - 30 MIU pre-filled syringe. - 48 MIU pre-filled syringe. TevaGrastim is licensed for the same indications
Dublin - Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Drug Price/Cost Debate: Coping with Escalating Pricing Pressures" to their offering. Insinuations of profiteering were made against an H1N1 swine flu vaccine manufacturer in the summer of 2009.
Q Chip, a biopharmaceutical drug delivery company, is developing a range of sustained-release biosimilars using its patented Q-Sphera bioencapsulation platform. The first two drugs under development using the Q-Sphera delivery system are the biosimilars, Q-Leuprolide and Q-Octreotide. Encapsulation of biotherapies into bioresorbable microspheres en
Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Drug Price/Cost Debate: Coping with Escalating Pricing Pressures" to their offering. Insinuations of profiteering were made against an H1N1 swine flu vaccine manufacturer in the summer of 2009.
Nov. 16Updated 12:41 p.m. with a response from Luetkemeyer. Missouri U.S. Rep. Blaine Luetkemeyer was one of several members of Congress to submit a statement on the health care bill using the exact language submitted by biotech lobbyists, the New York Times reported this weekend.
